Could we engineer humans to reduce Type 2 Diabetes, metabolic syndrome and Gout?

  • 0 Replies
  • 1147 Views

0 Members and 1 Guest are viewing this topic.

*

Offline evan_au

  • Neilep Level Member
  • ******
  • 4261
    • View Profile
Most species of mammals have an enzyme in the liver called Uricase; it breaks down uric acid.

However, humans and most apes have a corrupted genetic pathway to synthesise Uricase. This leads to a buildup of Uric Acid in the bloodstream. This directly causes gout in some people, but has been implicated in the explosion of fatty liver, metabolic syndrome and Type 2 diabetes in the worlds richest countries.

Could we restore the genetic pathway to produce Uricase, reducing the impact of these non-contagious diseases?

As both Uric Acid and Abscorbic Acid are both powerful antioxidants, Abscorbic acid synthesis would probably need to be restored before restoring Uricase functionality.